X4 Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
X4 Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker XFOR.
X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candidate, XOLREMDI (also known as mavorixafor), is an orally administered, small-molecule antagonist specifically designed to target the chemokine receptor CXCR4. This compound is currently undergoing Phase 3 clinical...
Can you invest in X4 Pharmaceuticals, Inc.?
Yes. X4 Pharmaceuticals, Inc. trades publicly on NASDAQ as XFOR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for X4 Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.